Here we showed that high CD8 TIL in the TNC stroma and combined high TNC and CXCL12 expression are parameters that define the immune exclusion phenotype which correlates with shorter survival of breast cancer patients that could have therapeutic value as seen in the preclinical models upon CXCR4 inhibition (Fig 9). This evidence concerns the gene CXCL12 and breast cancer.